These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 571607)

  • 21. Simultaneous catalepsy and apomorphine-induced stereotypic behavior in mice.
    Yurek DM; Randall PK
    Life Sci; 1985 Nov; 37(18):1665-73. PubMed ID: 4058245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of unilateral carotid occlusion on apomorphine-induced turning in rats.
    Mears A; Barnett A
    Arch Int Pharmacodyn Ther; 1974 Sep; 211(1):128-32. PubMed ID: 4477705
    [No Abstract]   [Full Text] [Related]  

  • 23. Dissociation by the aporphine derivatives of the stereotypic and hyperactivity responses resulting from injections into the nucleus accumbens septi.
    Costall B; Naylor RJ; Neumeyer JL
    J Pharm Pharmacol; 1975 Nov; 27(11):875-7. PubMed ID: 1503
    [No Abstract]   [Full Text] [Related]  

  • 24. Possible noradrenergic involvement in naloxone potentiation of apomorphine-induced stereotypic climbing in mice.
    Quock RM; Bloom AS; Sadowski JA
    Pharmacol Biochem Behav; 1984 Nov; 21(5):733-6. PubMed ID: 6096896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of penfluridol and other drugs on apomorphine-induced stereotyped behavior in monkeys.
    Shintomi K; Yamamura M
    Eur J Pharmacol; 1975 Apr; 31(2):273-80. PubMed ID: 1171014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methodone interaction with apomorphine- and amphetamine-induced turning.
    Stratten WP
    Res Commun Chem Pathol Pharmacol; 1975 Aug; 11(4):675-8. PubMed ID: 1237160
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of thioridazine on apomorphine-elicited stereotypic behavior and motor activity.
    Lai H; Carino MA; Sperry R; Horita A
    Pharmacol Biochem Behav; 1980 Sep; 13(3):397-401. PubMed ID: 7191570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of intrastriatal injections of atropine and methacholine on the apomorphine-induced gnawing in the rabbit.
    Wolfarth S; Kolasiewicz W
    Pharmacol Biochem Behav; 1977 Jan; 6(1):5-10. PubMed ID: 557798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurochemical and behavioral correlates of chronic apomorphine administration in the rat.
    Kenny M; Leonard BE
    Adv Biochem Psychopharmacol; 1978; 19():347-9. PubMed ID: 567934
    [No Abstract]   [Full Text] [Related]  

  • 30. Apomorphine and piribedil in rats: biochemical and pharmacologic studies.
    Butterworth RF; Poignant JC; Barbeau A
    Adv Neurol; 1975; 9():307-26. PubMed ID: 1170716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An objective and sensitive method for quantitative measurement of stereotyped gnawing.
    Kolasiewicz W; Wolfarth S
    Pharmacol Biochem Behav; 1976 Feb; 4(2):201-2. PubMed ID: 944454
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of the dopaminergic effects of apomorphine and (-)-N-n-propylnorapomorphine.
    Menon MK; Clark WG; Neumeyer JL
    Eur J Pharmacol; 1978 Nov; 52(1):1-9. PubMed ID: 569056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Choline chloride in methylphenidate- and apomorphine-induced stereotypy.
    Davis KL; Hollister LE; Vento AL; Simonton S
    Life Sci; 1978 Jun; 22(24):2171-7. PubMed ID: 566835
    [No Abstract]   [Full Text] [Related]  

  • 34. Bromocriptine-induced behavioral hypersensitivity: implications for the therapy of parkinsonism.
    Nausieda PA; Weiner WJ; Kanapa DJ; Klawans HL
    Neurology; 1978 Nov; 28(11):1183-8. PubMed ID: 568738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Naloxone potentiation of apomorphine-induced stereotypic climbing in mice and interaction with mu-, sigma- and kappa-opiate drugs.
    Quock RM
    Life Sci; 1982 Dec; 31(25):2907-11. PubMed ID: 6298534
    [No Abstract]   [Full Text] [Related]  

  • 36. A comparison of apomorphine, bromocriptine and Sandoz CM 29-712 (6-methyl-8a-cyanomethyl-ergoline-l) in four different turning models in the rat [proceedings].
    Jaton AL; Loew DM; Vigouret JM
    Br J Pharmacol; 1978 Mar; 62(3):395P. PubMed ID: 565235
    [No Abstract]   [Full Text] [Related]  

  • 37. Modification of apomorphine induced stereotypies in rates by aversive conditioning.
    Gale KN; Murray JP; Horita A
    Proc West Pharmacol Soc; 1975; 18():375-9. PubMed ID: 1237143
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of structural and stereoisomers of apomorphine on stereotyped behavior of the rat.
    Schoenfeld RI; Neumeyer JL; Dafeldecker W; Roffler-Tarlov S
    Eur J Pharmacol; 1975 Jan; 30(1):63-8. PubMed ID: 1168137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tolerance to stereotyped behaviour and to decrease in striatal homovanillic acid levels after repeated treatment with apomorphine dipivaloyl ester.
    Worms P; Scatton B
    Eur J Pharmacol; 1977 Oct; 45(4):395-6. PubMed ID: 562764
    [No Abstract]   [Full Text] [Related]  

  • 40. Dissociation between spontaneously emitted and apomorphine-induced stereotypy in Peromyscus maniculatus bairdii.
    Presti MF; Powell SB; Lewis MH
    Physiol Behav; 2002 Mar; 75(3):347-53. PubMed ID: 11897261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.